2008
DOI: 10.1016/j.pupt.2007.09.003
|View full text |Cite
|
Sign up to set email alerts
|

The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
27
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(30 citation statements)
references
References 45 publications
3
27
0
Order By: Relevance
“…Importantly, unlike other TRP inhibitors, SK&F 96365 and 2-aminoethyldiphenylborate, BTP2 is selective to TRP channels and does not affect Ca 2ϩ handling by mitochondria or ER, or K ϩ channels or voltage-dependent Ca 2ϩ channels (25)(26)(27). Pharmacological profiles of BTP2 have been investigated in vitro and in vivo to evaluate its potential as a therapeutic anti-asthma drug (28). However, BTP2 failed to show subtype selectivity among members of the TRPC family, inhibiting both TRPC3 and TRPC5 (27).…”
Section: Canonical Transient Receptor Potential (Trpc) Channels Contrmentioning
confidence: 99%
“…Importantly, unlike other TRP inhibitors, SK&F 96365 and 2-aminoethyldiphenylborate, BTP2 is selective to TRP channels and does not affect Ca 2ϩ handling by mitochondria or ER, or K ϩ channels or voltage-dependent Ca 2ϩ channels (25)(26)(27). Pharmacological profiles of BTP2 have been investigated in vitro and in vivo to evaluate its potential as a therapeutic anti-asthma drug (28). However, BTP2 failed to show subtype selectivity among members of the TRPC family, inhibiting both TRPC3 and TRPC5 (27).…”
Section: Canonical Transient Receptor Potential (Trpc) Channels Contrmentioning
confidence: 99%
“…In this study, BTP2 was shown to inhibit not only production of IL-2, but also of IL-5 and IFN-g, and T-cell proliferation. Both antigen-induced histamine release from an IgE-primed rat basophilic leukemia cell line (RBL-2H3) and IL-5 and IL-13 production in human peripheral blood cells were blocked by BTP2 with an IC 50 in the low nanomolar range [106]. BTP2 suppressed ovalbumin-induced airway hyperresponsiveness and bronchoconstriction by inhibiting the I CRAC -induced inflammatory mediator and cytokine production [106].…”
Section: Btp2 To Examine the Physiological Function And Therapeutic Usementioning
confidence: 99%
“…Both antigen-induced histamine release from an IgE-primed rat basophilic leukemia cell line (RBL-2H3) and IL-5 and IL-13 production in human peripheral blood cells were blocked by BTP2 with an IC 50 in the low nanomolar range [106]. BTP2 suppressed ovalbumin-induced airway hyperresponsiveness and bronchoconstriction by inhibiting the I CRAC -induced inflammatory mediator and cytokine production [106]. In addition, BTP2 has been shown to prevent antigen-induced airway eosinophil infiltration and late-phase asthmatic responses, probably by inhibition of I CRACinduced production of cytokines and inflammatory mediators in Th2 cells [107].…”
Section: Btp2 To Examine the Physiological Function And Therapeutic Usementioning
confidence: 99%
“…Experimental and clinical studies have demonstrated that voltage-gated Ca 2ϩ channel blockers have no obvious effects on the regulation of airway hyperresponsiveness (13); in contrast, SOC channel blockers have been shown to be effective in attenuating airway hyperresponsiveness in ovalbumin-sensitized guinea pigs (20 (9,16). The underlying mechanisms that transfer the signal of ER store depletion to SOC channels in the PM are not understood.…”
mentioning
confidence: 99%